St. Anna Children's Cancer Research Institute (CCRI)
Sarah Grissenberger, PhD, is a postdoctoral researcher at St. Anna Children's Cancer Research Institute (CCRI) since March 2018, focusing on establishing models of Ewing sarcoma in zebrafish. Prior experience includes serving as a scientific assistant and completing a master's thesis at Karl-Franzens-Universität Graz, where research involved 3D in vitro studies on antitumor peptides against human malignant melanoma. Additional internships at Karl-Franzens-Universität Graz and BHS Linz provided experience in antitumor peptide characterization and cytogenetic analysis. Sarah Grissenberger obtained a PhD in malignant diseases from the Medical University of Vienna, following a Master of Science in biochemistry and molecular biomedicine and a Bachelor of Science in molecular biology from Technische Universität Graz. Academic education was preceded by a Matura focused on natural sciences at Bundesrealgymnasium Waidhofen/Ybbs.
This person is not in any offices
St. Anna Children's Cancer Research Institute (CCRI)
The St. Anna Children's Cancer Research Institute (St Anna CCRI), located in the center of Vienna, the world's most livable city and one of Europe's most important places for biomedical research and life sciences, is an internationally renowned multidisciplinary research institution with the aim to develop and optimize diagnostic, prognostic, and therapeutic strategies for the treatment of children and adolescents with cancer. To achieve this goal we combine basic research with translational and clinical research and focus on the specific characteristics of childhood tumor diseases in order to provide young patients with the best possible and most innovative therapies. Dedicated research groups in the fields of tumor genomics and epigenomics, immunology, molecular biology, cell biology, bioinformatics and clinical research are working together to harmonize scientific findings with the clinical needs of physicians to ultimately improve the wellbeing of our patients. Through close cooperation between clinic and research, the CCRI provides an ideal environment for cutting-edge research and its translation into clinical practice. To achieve our ultimate goal of advancing the well-being of patients, the CCRI constantly pushes scientific boundaries and strongly promotes close collaboration and exchange with external institutions like the Medical University of Vienna, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA) and the Institute of Molecular Pathology (IMP).